GORDIAN Trademark
Trademark Overview
On Wednesday, February 21, 2024, a trademark application was filed for GORDIAN with the United States Patent and Trademark Office. The USPTO has given the GORDIAN trademark a serial number of 98413936. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, May 22, 2026. This trademark is owned by Gordian Biotechnology. The GORDIAN trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer; pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer
Providing medical information on aging and complex multigenic diseases
Pharmaceutical and biological drug research and development services; research and development of pharmaceutical and biotechnology fields, namely, cell- and gene-based therapy research and development services; providing information about medical and scientific research on aging and complex multigenic diseases; providing information about medical and scientific research, namely, providing information on pharmaceutical drug, biological drug, and cell- and gene-based therapy research and development; providing scientific information on computational biology, machine learning, and bioinformatics
General Information
| Serial Number | 98413936 |
| Word Mark | GORDIAN |
| Filing Date | Wednesday, February 21, 2024 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Friday, May 22, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, October 15, 2024 |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer; pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer |
| Goods and Services | Providing medical information on aging and complex multigenic diseases |
| Description of Mark | The mark consists of the wording "Gordian" with a partial "a" and a diagonal edge extending from the top of the letter "d" to the bottom of the letter "a". |
| Goods and Services | Pharmaceutical and biological drug research and development services; research and development of pharmaceutical and biotechnology fields, namely, cell- and gene-based therapy research and development services; providing information about medical and scientific research on aging and complex multigenic diseases; providing information about medical and scientific research, namely, providing information on pharmaceutical drug, biological drug, and cell- and gene-based therapy research and development; providing scientific information on computational biology, machine learning, and bioinformatics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 21, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 21, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 21, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Gordian Biotechnology |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080
US |
| Party Name | Gordian Biotechnology |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, February 21, 2024 | NEW APPLICATION ENTERED |
| Sunday, June 30, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, September 11, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, September 11, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 15, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 15, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 26, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, May 21, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 21, 2025 | SOU EXTENSION 1 FILED |
| Wednesday, May 21, 2025 | SOU EXTENSION 1 GRANTED |
| Wednesday, May 21, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, November 21, 2025 | SOU TEAS EXTENSION RECEIVED |
| Friday, November 21, 2025 | SOU EXTENSION 2 FILED |
| Friday, November 21, 2025 | SOU EXTENSION 2 GRANTED |
| Tuesday, December 2, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, May 22, 2026 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 22, 2026 | SOU EXTENSION 3 FILED |
| Friday, May 22, 2026 | SOU EXTENSION 3 GRANTED |
| Saturday, May 23, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
